Efficacy of immune checkpoint inhibitors in different types of melanoma

E. Rossi; Giovanni Schinzari; B. A. Maiorano; G. Indellicati; Stefani A. Di; M. M. Pagliara; S. M. Fragomeni; Luca E. V. De; M. G. Sammarco; Giorgia Garganese; Jacopo Galli; M. A. Blasi; G. Paludetti; Giovanni Scambia; Ketty Peris; Giampaolo Tortora

doi:10.1080/21645515.2020.1771986

Efficacy of immune checkpoint inhibitors in different types of melanoma

E. Rossi^*, Giovanni Schinzari, B. A. Maiorano, G. Indellicati, Stefani A. Di, M. M. Pagliara, S. M. Fragomeni, Luca E. V. De, M. G. Sammarco, Giorgia Garganese, Jacopo Galli, M. A. Blasi, G. Paludetti, Giovanni Scambia, Ketty Peris, Giampaolo Tortora

^*Autore corrispondente per questo lavoro

Risultato della ricerca: Contributo in rivista › Articolo in rivista

5 Citazioni (Scopus)

Abstract

Immunotherapy can be used for cutaneous, mucosal, uveal and conjunctival melanoma. Nevertheless, we cannot expect the same benefit from checkpoint inhibitors for all the types of melanoma. The different biological features can explain the variable efficacy. The main results obtained with immune checkpoint inhibitors in the various types of melanoma were reviewed.

Lingua originale	English
pagine (da-a)	1-10
Numero di pagine	10
Rivista	Human Vaccines and Immunotherapeutics
Volume	17
Numero di pubblicazione	1
DOI	https://doi.org/10.1080/21645515.2020.1771986
Stato di pubblicazione	Pubblicato - 2020

All Science Journal Classification (ASJC) codes

Immunology and Allergy
Immunology
Pharmacology

Keywords

Immunotherapy
conjunctival melanoma
melanoma
uveal melanoma

Accesso al documento

10.1080/21645515.2020.1771986

Altri file e collegamenti

Cita questo

Rossi, E., Schinzari, G., Maiorano, B. A., Indellicati, G., Di, S. A., Pagliara, M. M., Fragomeni, S. M., De, L. E. V., Sammarco, M. G., Garganese, G., Galli, J., Blasi, M. A., Paludetti, G., Scambia, G., Peris, K., & Tortora, G. (2020). Efficacy of immune checkpoint inhibitors in different types of melanoma. Human Vaccines and Immunotherapeutics, 17(1), 1-10. https://doi.org/10.1080/21645515.2020.1771986

@article{30f73d462d494c3089923e4ebda7dcac,

title = "Efficacy of immune checkpoint inhibitors in different types of melanoma",

abstract = "Immunotherapy can be used for cutaneous, mucosal, uveal and conjunctival melanoma. Nevertheless, we cannot expect the same benefit from checkpoint inhibitors for all the types of melanoma. The different biological features can explain the variable efficacy. The main results obtained with immune checkpoint inhibitors in the various types of melanoma were reviewed.",

keywords = "Immunotherapy, conjunctival melanoma, melanoma, uveal melanoma, Immunotherapy, conjunctival melanoma, melanoma, uveal melanoma",

author = "E. Rossi and Giovanni Schinzari and Maiorano, {B. A.} and G. Indellicati and Di, {Stefani A.} and Pagliara, {M. M.} and Fragomeni, {S. M.} and De, {Luca E. V.} and Sammarco, {M. G.} and Giorgia Garganese and Jacopo Galli and Blasi, {M. A.} and G. Paludetti and Giovanni Scambia and Ketty Peris and Giampaolo Tortora",

year = "2020",

doi = "10.1080/21645515.2020.1771986",

language = "English",

volume = "17",

pages = "1--10",

journal = "Human Vaccines and Immunotherapeutics",

issn = "2164-5515",

publisher = "Landes Bioscience",

number = "1",

}

Rossi, E, Schinzari, G, Maiorano, BA, Indellicati, G, Di, SA, Pagliara, MM, Fragomeni, SM, De, LEV, Sammarco, MG, Garganese, G , Galli, J, Blasi, MA, Paludetti, G, Scambia, G , Peris, K & Tortora, G 2020, 'Efficacy of immune checkpoint inhibitors in different types of melanoma', Human Vaccines and Immunotherapeutics, vol. 17, n. 1, pagg. 1-10. https://doi.org/10.1080/21645515.2020.1771986

TY - JOUR

T1 - Efficacy of immune checkpoint inhibitors in different types of melanoma

AU - Rossi, E.

AU - Schinzari, Giovanni

AU - Maiorano, B. A.

AU - Indellicati, G.

AU - Di, Stefani A.

AU - Pagliara, M. M.

AU - Fragomeni, S. M.

AU - De, Luca E. V.

AU - Sammarco, M. G.

AU - Garganese, Giorgia

AU - Galli, Jacopo

AU - Blasi, M. A.

AU - Paludetti, G.

AU - Scambia, Giovanni

AU - Peris, Ketty

AU - Tortora, Giampaolo

PY - 2020

Y1 - 2020

N2 - Immunotherapy can be used for cutaneous, mucosal, uveal and conjunctival melanoma. Nevertheless, we cannot expect the same benefit from checkpoint inhibitors for all the types of melanoma. The different biological features can explain the variable efficacy. The main results obtained with immune checkpoint inhibitors in the various types of melanoma were reviewed.

AB - Immunotherapy can be used for cutaneous, mucosal, uveal and conjunctival melanoma. Nevertheless, we cannot expect the same benefit from checkpoint inhibitors for all the types of melanoma. The different biological features can explain the variable efficacy. The main results obtained with immune checkpoint inhibitors in the various types of melanoma were reviewed.

KW - Immunotherapy

KW - conjunctival melanoma

KW - melanoma

KW - uveal melanoma

KW - Immunotherapy

KW - conjunctival melanoma

KW - melanoma

KW - uveal melanoma

UR - https://publicatt.unicatt.it/handle/10807/168629

UR - https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85088141955&origin=inward

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85088141955&origin=inward

U2 - 10.1080/21645515.2020.1771986

DO - 10.1080/21645515.2020.1771986

M3 - Article

SN - 2164-5515

VL - 17

SP - 1

EP - 10

JO - Human Vaccines and Immunotherapeutics

JF - Human Vaccines and Immunotherapeutics

IS - 1

ER -

Efficacy of immune checkpoint inhibitors in different types of melanoma

Abstract

All Science Journal Classification (ASJC) codes

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo